ArticleBMC cancer2025

Synergistic effects of PD-1 antibody and chemotherapy followed by surgery-centric local treatment in patients with limited-metastatic gastric or gastroesophageal adenocarcinoma (ROSETTE trial): an open-label, single-center, randomized phase 2 trial.

Ying Ying Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.